LATEST UPDATES » Vol 22, No 11, November 2018 – The Asian Cancer - War on liver cancer       » 2018 Nobel Prize in Physiology or Medicine winners       » Women more prone to selected chemotherapy side effects       » Tibetan fungus could help fight liver cancer       » Standards for TCM decoction to be applied globally       » RMB200 million donation to build Tsinghua University Biomedical Sciences Building      
Digital tool when well-used, it is Passion

With a soaring global population, vast numbers of people are facing living in cities that are built for much smaller populations with very different needs. This puts our environment at risk by wasting resources such as land, water and energy, and makes cities harder to manage logistically. A diverse range of disciplines are helping solve these challenges, aided by a suite of digital tools that allow scientists and city planners to see and explore the futures we are creating and their effects on their inhabitants and the planet as a whole.

Dassault Systèmes (DS) has committed a significant of interest in urban planning. Virtual Singapore may be a resemblance of a catalyst for their previous assignments in aerospace. It harmonizes the value of Computed Tomography to the future, and it is the first of a kind worldwide programme; with Singapore as the reference. DS has done several simulative work and simulation projects which include: the design of sports gears for optimal performance, the safety-design of Formula 1 (F1) racing circuits, earthquakes-resistance of buildings, etc.

‘Consumers are becoming more demanding than ever before and this is what we anticipate. This phenomenon will continue and there will be constant changes to the priorities during purchasing,’ says Mr Sylvain Laurent, the executive vice-president of DS Worldwide Business Transformation & Global Field Operations in Asia. DS is a Business-to-Business company, and it has placed major focus on the development of new technologies to transform the way products are designed, produced and supported. To cope with the greying population in developed nations, the Managing Director of DS in Asia Pacific South, Mr Samson Khaou expressed the constraints that have to be taken into account for an environment and a business to be sustainable. ‘We want to transform companies and factories. The approach is to create knowledge-based training, to train workers with the necessary skills to work on digital data. It will no longer be about manpower. There will be more automation, and hence technology and skilled workforce enhance the workflow in global supply chain. ‘

What are the takes for Pharmaceutical industries?

The growth of biologics drug development and the challenges of managing and leveraging biologics data, especially in development, demand an improved informatics environment supporting the efficient and compliant management of biologics data. DS BIOVIA’s integrated Biologics Development solution provides such an environment—accelerating innovation, reducing cycle times and ultimately enabling customers to bring better products to market faster. By providing an end-to-end platform, it is cost-effective for the business.

BIOVIA provides a fully integrated Biologics Development solution supporting the management of all data related to the characterization of substances, the development of formulations, manufacturing processes and related testing. The BIOVIA Foundation provides the underlying technology framework for integrating equipment, data systems, applications, analysis tools and other business or laboratory informatics systems. As a result, the BIOVIA solution functions as an integration hub improving efficiency and compliance along the entire Biologics Development value chain.

The Living Heart Project: Realistic Simulation to Human Modeling, and to revolutionize patient care

The SIMULIA Living Heart Human Model is a high-fidelity multiphysics model of a healthy, 4-chamber adult human heart and proximal vasculature. The dynamic response of the Living Heart is governed by realistic electrical, structural, and fluid (blood) flow physics. With this model, medical professionals, researchers, and device manufacturers will be able to rapidly conduct virtual experiments in a highly realistic 3D environment. The Living Heart can readily be used to study cardiac defects or diseased states and explore treatment options by modifying its geometry, loading, or electromechanical properties. In addition, medical devices can be inserted into the model to study their influence on cardiac function, validate their efficacy, and predict their reliability under a wide range of operating conditions.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, provides business and people with virtual universes to imagine sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and supported. Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual world to improve the real world. The group brings value to over 190,000 customers of all sizes in all industries in more than 140 countries. To learn more about the SIMULIA Living Heart Human Model, visit: www.3ds.com/heart.

Click here for the complete issue.

news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
Asia Pacific Biotech News

APBN Editorial Calendar 2018
Obesity / Outlook for 2018
Searching for the fountain of youth
Women in Science - Making a difference
Digestive health in the 21st century - Trust your guts
Dental health - The root to good health
Cancer - Therapies and strategies for better patient outcomes
Water management - Technologies for biotech and pharmaceutical industries
Regenerative technology - Meat of the future
Doctor Robot - The digital healthcare revolution
Bones / Breast cancer
Liver health / Top science research nations & institutions
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy